Published in Lancet on November 15, 1986
Acute neuromuscular respiratory paralysis. J Neurol Neurosurg Psychiatry (1993) 1.72
Plasma exchange in neurological diseases. Br Med J (Clin Res Ed) (1987) 0.79
Intravenous immune globulin in the Guillain-Barré syndrome. Clin Exp Immunol (1994) 0.75
Sympathetic reflex latencies and conduction velocities in normal man. J Neurol Sci (1980) 2.35
Focal sensory-motor seizures of spinal origin. Lancet (1968) 1.71
Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiatry (1978) 1.68
Peripheral sympathetic neural activity in conscious humans. Annu Rev Physiol (1988) 1.68
Variability of sensory threshold determination in clinical use. J Neurol Sci (1981) 1.62
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs. Mult Scler (2012) 1.59
Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet (1984) 1.58
Muscle sympathetic activity and norepinephrine release during mental challenge in humans. Am J Physiol (1989) 1.50
The benign and malignant forms of orgasmic cephalgia. Headache (1974) 1.48
Practical guidelines for the use of NESP in treating renal anaemia. Nephrol Dial Transplant (2001) 1.47
Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin. Scand J Gastroenterol (1998) 1.40
Sympathetic outflow in man after anaesthesia of the glossopharyngeal and vagus nerves. Brain (1985) 1.40
Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency. Nephron (1989) 1.39
The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia (1992) 1.26
HLA as a marker of the hemochromatosis gene in Sweden. Hum Genet (1984) 1.22
Sympathetic response to oral carbohydrate administration. Evidence from microelectrode nerve recordings. J Clin Invest (1989) 1.20
The diving response in man: effects on sympathetic activity in muscle and skin nerve fascicles. J Physiol (1986) 1.11
Renal replacement therapy in Sweden. Scand J Urol Nephrol (2004) 1.10
Guillain-Barré syndrome following zimeldine treatment. J Neurol Neurosurg Psychiatry (1985) 1.08
Chronic cryptogenic polyneuropathy. The search for a cause. Acta Neurol Scand (1983) 1.06
Sympathetic outflow in human muscle nerves increases during hypoglycemia. Diabetes (1986) 1.05
The influence of transphyseal drilling and tendon grafting on bone growth: an experimental study in the rabbit. J Pediatr Orthop (1998) 1.04
Sympathetic outflow to the hand in patients with Raynaud's phenomenon. Cardiovasc Res (1985) 1.03
Acute pandysautonomia and severe sensory deficit with poor recovery. A clinical, neurophysiological and pathological case study. J Neurol Neurosurg Psychiatry (1983) 1.02
Serum prolactin in patients with hypothalamus and pituitary disorders. J Neurosurg (1981) 1.02
Pharmacokinetics and oral bioavailability of pyridostigmine in man. Eur J Clin Pharmacol (1980) 1.02
Effect of noxious stimulation on sympathetic vasoconstrictor outflow to human muscles. J Physiol (1995) 0.99
Sympathetic reflex latencies and conduction velocities in patients with polyneuropathy. J Neurol Sci (1980) 0.99
Myelopathy after clioquinol treatment. Lancet (1971) 0.99
Antibodies to myelin-associated glycoprotein are found in cerebrospinal fluid in polyneuropathy associated with monoclonal serum IgM. Arch Neurol (1991) 0.96
[A computerized system for regional management of incidents is now tested. A complement to the Lex Maria system, indicates unobserved risks]. Lakartidningen (1999) 0.96
HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course. Acta Endocrinol (Copenh) (1981) 0.95
HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis. Tissue Antigens (1978) 0.94
Follow-up study of muscle function in children of mothers with myasthenia gravis during pregnancy. J Child Neurol (1992) 0.94
Dyggve-Melchior-Clausen dysplasia. Morphological and biochemical findings in cartilage growth zones. Acta Paediatr Scand (1983) 0.94
Radioimmunoassay of serum myoglobin in neuromuscular diseases. J Neurol Neurosurg Psychiatry (1981) 0.93
HL-A frequencies in Crohn's disease and ulcerative colitis. Tissue Antigens (1976) 0.93
Paroxysmal itching in multiple sclerosis. Br J Dermatol (1976) 0.93
Microneurographic findings in diabetic polyneuropathy with special reference to sympathetic nerve activity. Diabetologia (1982) 0.93
Effect of normalization of hematocrit on brain circulation and metabolism in hemodialysis patients. J Am Soc Nephrol (1999) 0.92
Incidence and clinical importance of renal tubular defects in recurrent renal stone formers. Nephron (1980) 0.92
World apheresis registry 2003-2007 data. Transfus Apher Sci (2008) 0.92
Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid. Lancet (1989) 0.92
Cardiovascular and sympathoadrenal responses to mental stress: a study of sensory intake and rejection reactions. Acta Physiol Scand (1990) 0.91
Microneurographic evidence of excessive sympathetic outflow in the Guillain-Barré syndrome. Brain (1983) 0.91
Weekly headache periodicity and the effect of weather changes on headache. Int J Biometeorol (1981) 0.90
The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects. Br J Clin Pharmacol (1990) 0.90
Family history of renal stones in recurrent stone patients. Br J Urol (1985) 0.89
Bilateral and recurrent optic neuritis in multiple sclerosis. Acta Neurol Scand (2011) 0.89
HL-A frequencies in patients with myasthenia gravis. Tissue Antigens (1973) 0.89
Inability of UV-irradiated lymphocytes to stimulate allogeneic cells in mixed lymphocyte culture. Int Arch Allergy Appl Immunol (1971) 0.89
Newborn infants to myasthenic mothers: a clinical study and an investigation of acetylcholine receptor antibodies in 17 children. Neurology (1983) 0.89
Signs of reinnervation in myasthenia gravis. Muscle Nerve (1982) 0.88
Treatment of the Guillain-Barré syndrome by plasmapheresis. Arch Neurol (1982) 0.88
Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study. J Neurol Neurosurg Psychiatry (1981) 0.87
Exploring sex differences in case fatality in acute myocardial infarction or coronary death events in the northern Sweden MONICA Project. J Intern Med (2002) 0.86
Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study. Int J Artif Organs (1999) 0.86
Lung density for assessment of hydration status in hemodialysis patients using the computed tomographic densitometry technique. Kidney Int (1997) 0.84
Assessing tissue damage in multiple sclerosis: a biomarker approach. Acta Neurol Scand (2014) 0.84
HLA-types, C-peptide and insulin antibodies in juvenile diabetes. Diabetologia (1977) 0.84
Influence of the HLA-DR4 antigen and iodine status on the development of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab (1985) 0.84
Genetic heterogeneity at the glycosyltransferase loci underlying the GLOB blood group system and collection. Br J Haematol (2004) 0.84
Heterogeneity of DNA distribution pattern in colorectal carcinoma. A microspectrophotometric study of fine needle aspirates. Anal Quant Cytol Histol (1990) 0.84
No association with HLA-DR, -DQ or -DP alleles in Guillain-Barré syndrome. J Neuroimmunol (1991) 0.84
Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography. Acta Physiol Scand (2001) 0.83
Treatment of renal calcium stone disease with the synthetic glycosaminoglycan pentosan polysulphate. World J Urol (1994) 0.83
Anemia associated with advanced prostatic adenocarcinoma: effects of recombinant human erythropoietin. Prostate (1997) 0.83
The postpartum period constitutes an important risk for the development of clinical Graves' disease in young women. Acta Endocrinol (Copenh) (1987) 0.83
Treatment of pruritus in cholestatic jaundice by bilirubin- and bile acid-adsorbing resin column plasma perfusion. Scand J Gastroenterol (1992) 0.83
Early relapse of acute inflammatory polyradiculoneuropathy after successful treatment with plasma exchange. Acta Neurol Scand (1988) 0.83
Magnesium metabolism in renal stone disease. Invest Urol (1980) 0.82
A pharmacokinetic study of neostigmine in man using gas chromatography-mass spectrometry. Eur J Clin Pharmacol (1979) 0.82
Urinary excretion of urate in renal calcium stone disease and in renal tubular acidification disturbances. J Urol (1982) 0.82
The relation between urinary tract infections and stone composition in renal stone formers. Scand J Urol Nephrol (1989) 0.82
HLA antigens in females with ankylosing spondylitis and other forms of seronegative rheumatic diseases. Scand J Rheumatol (1978) 0.82
Reversible Horner's syndrome associated with spontaneous pneumothorax. Scand J Respir Dis (1971) 0.82
Assessment of erythropoiesis following renal transplantation. Eur J Haematol (1997) 0.81
Plasmapheresis in the treatment of primary septic shock in humans. Scand J Infect Dis (1993) 0.81
Prospective study of symptoms after human microneurography. Acta Physiol Scand (1989) 0.81
Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection. J Antimicrob Chemother (1996) 0.81
Effects of magnesium hydroxide in renal stone disease. J Am Coll Nutr (1982) 0.81
Serum erythropoietin levels in the immediate kidney-posttransplant period. Nephron (1992) 0.81
Clinical pharmacology of pyridostigmine and neostigmine in patients with myasthenia gravis. J Neurol Neurosurg Psychiatry (1983) 0.81
Experience with the Hemasite device in haemodialysis and haemofiltration patients with vascular access problems. Nephrol Dial Transplant (1990) 0.81
Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial. Diabetologia (1985) 0.81
Blood viscosity and peripheral vascular resistance in patients with untreated essential hypertension. J Hypertens (1993) 0.80
HLA frequencies in patients with cystic fibrosis. Tissue Antigens (1977) 0.80
Computed tomographic measurement of lung density changes in lung water with hemodialysis. Nephron (1997) 0.80
Kinetic studies on epiphyseal growth cartilage in the normal mouse. Bone (1998) 0.80
Proteoglycans and glycosaminoglycans in phenytoin-induced gingival overgrowth. J Periodontal Res (1986) 0.80